Compare GBTG & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GBTG | TWST |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.0B |
| IPO Year | 2020 | 2018 |
| Metric | GBTG | TWST |
|---|---|---|
| Price | $5.64 | $46.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $10.25 | ★ $48.75 |
| AVG Volume (30 Days) | ★ 1.7M | 1.4M |
| Earning Date | 05-19-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $2,423,000,000.00 | $376,572,000.00 |
| Revenue This Year | $14.24 | $18.89 |
| Revenue Next Year | $19.98 | $15.28 |
| P/E Ratio | $111.20 | ★ N/A |
| Revenue Growth | 5.81 | ★ 20.32 |
| 52 Week Low | $4.96 | $23.30 |
| 52 Week High | $8.64 | $57.88 |
| Indicator | GBTG | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 44.00 | 50.69 |
| Support Level | $4.96 | $25.67 |
| Resistance Level | $6.79 | $57.88 |
| Average True Range (ATR) | 0.31 | 3.10 |
| MACD | 0.11 | -0.90 |
| Stochastic Oscillator | 92.52 | 26.12 |
Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.